On July 4th, Gelonhui reported that an investor asked Dayang Biotech Group (003017.SZ) on the investor interaction platform, "Does the company have any synthetic biology-related businesses?" The company responded that the company does not currently have any synthetic biology-related businesses.
- Headlines
- Zhejiang Dayang Biotech Group (003017.SZ): There is currently no business related to synthetic biology.
大洋生物(003017.SZ)：暂时没有合成生物相关业务
Zhejiang Dayang Biotech Group (003017.SZ): There is currently no business related to synthetic biology.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
16:20
Haitong Securities: The Hong Kong Securities Regulatory Commission has approved Cathay Pacific Junan to become the majority shareholder of overseas subsidiaries related to Haitong Securities after this merger
Haitong-0.26%
16:20
The box office for the 2024 New Year's release films has surpassed 2 billion.
16:14
According to the Nikkei News: The Japan Fair Trade Commission is expected to rule that Google (GOOG.O) violated the Anti-Monopoly Law. The regulatory agency determined that the contracts signed by this USA Technology company with Smart Phone manufacturers unfairly restricted competition, harming the Internet Plus-Related search market.
GOOG+1.72%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.